Thai Healthcare Undervalued based on future growth

Results

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Medeze Group

Market Cap: ฿6.5b

Engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally.

MEDEZE

฿6.10

-0.8%

-25.6%

Master Style

Market Cap: ฿2.5b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿8.30

-9.3%

-69.0%